Company: AEMD
Filing Date: 2025-08-29
Form Type: S-1/A
Source: 0001683168-25-006537
Chunk: 85

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-29
Form: S-1/A
Chunk 85
---
 · 
 · | our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 filed with the SEC on June 26, 2025;                                                                                                                                                         
 our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the SEC on August 13, 2025;                                                                                                                                                        |
|:--|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| · | our definitive proxy statement on Schedule 14A filed with the SEC on April 18, 2025;                                                                                                                                                                                 |
| · | our Current                                                                                                                                                                                                                                                          
 Reports on Form 8-K filed with the SEC on May                                                                                                                                                                                                                        
 13, 2025, June 5, 2025, June                                                                                                                                                                                                                                         
 27, 2025, August 13, 2025                                                                                                                                                                                                                                            
 and August 21, 2025; and                                                                                                                                                                                                                                             |
| · | the description of our common stock, which is registered under Section 12 of the Exchange Act, in our registration statement on Form 8-A, filed with the SEC on July 8, 2015, including any amendment or reports filed for the purpose of updating such description. |

In addition,
all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of
the offering (excluding any information furnished rather than filed) shall be deemed to be incorporated by reference into this prospectus.

We will
provide to each person, including any beneficial owners, to whom a prospectus is delivered, a copy of any or all of the reports or documents
that have been incorporated by reference in the prospectus contained in the registration statement but not delivered with the prospectus.
We will provide these reports or documents upon written or oral request at no cost to the requester. You should direct any written requests
for documents to:

<div align='center'>Aethlon Medical, Inc.

11555 Sorrento Valley Road,
Suite 203

San Diego, California 92121

Telephone: (619) 941-0360</div>

You also
may access these filings through the SEC website at www.sec.gov or on our website at www.aethlonmedical.com. Information contained on
or accessible through our website is not a part of this prospectus or the registration statement of which it forms a part, and the inclusion
of our website address in this prospectus is an inactive